Grant RDF

• 127
• 128
• 129
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• more...

• Mechanism of Tgfbr2 in Chondroprotection
• Mechanism of Ultraviolet Radiation Induced Immune Tolerance
• Mechanism of Vangl2-Mediated Planar Cell Polarity Signaling in Heart Development
• Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans
• Mechanisms and Countermeasures of Halogen-Induced Injury to Pregnant Mice
• Mechanisms and Longitudinal Effects of Stigma on Women's Adherence and Outcomes
• Mechanisms and Therapy of Ischemic Sudden Cardiac Arrest
• Mechanisms and Therapy of Ischemic Sudden Cardiac Arrest - Core A
• Mechanisms and Therapy of Ischemic Sudden Cardiac Arrest - Project 3
• Mechanisms and Therapy of Ischemic Sudden Cardiac Arrest - Project 5
• Mechanisms by Which GSK3B Inhibition Enhances Nonhomologous End-Joining Repair
• Mechanisms by Which Retinoids Attenuate Hyperoxia-Induced Memory Deficit in Mice
• Mechanisms Controlling IL-10 Producing Intestinal Regulatory T Cells
• Mechanisms Controlling Regulatory T Cell Effector Function in IBD
• Mechanisms Elicited by Type I Interferons in Cutaneous Photocarcinogenesis
• Mechanisms for Tau Involvement in Alzheimer's Disease
• Mechanisms for the Benefit of Tau Reduction in Alzheimer Disease Models
• Mechanisms of Activity-Dependent Myelination in the Visual System
• Mechanisms of Acute Exercise on Cognition in MS: The MAX-Cog Study
• Mechanisms of Age-Dependent Nigral Neuron Loss in PINK1 Knockout Rats
• Mechanisms of Alpha-synuclein Mediated Inflammation in Multiple System Atrophy
• Mechanisms of and Therapies for Abnormal Mucus Adhesion and Clearance in CF
• Mechanisms of and Therapies for Abnormal Mucus Adhesion and Clearance in CF
• Mechanisms of Apoptotic Cell Clearance in the Human Stomach
• Mechanisms of Apoptotic Cell Clearance in the Human Stomach
• Mechanisms of B Cell Responses in Autoimmune Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituxibab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
• Mechanisms of C3 Effects in ARPKD Pathogenesis
• Mechanisms of Coagulation Abnormalities and Trauma
• Mechanisms of Copper Dysregulation in Schizophrenia
• Mechanisms of Daily Behavioral Symptom Experiences

• 127
• 128
• 129
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• more...